{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T04:54:06Z","timestamp":1776142446274,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012360","name":"Heart of England NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015846","name":"Llywodraeth Cymru","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015846","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.clon.2026.104069","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T15:48:36Z","timestamp":1769874516000},"page":"104069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Future Directions of the National Prostate Cancer Audit"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5406-8751","authenticated-orcid":false,"given":"J.K.H.","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8572-2832","authenticated-orcid":false,"given":"A.","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7470-3014","authenticated-orcid":false,"given":"J.","family":"Dodkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Parry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5140-8495","authenticated-orcid":false,"given":"E.","family":"Mayne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4417-2632","authenticated-orcid":false,"given":"A.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.Y.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G.","family":"Parry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.E.","family":"Cowling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.C.","family":"Tree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.W.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"van der Meulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2026.104069_bib1","series-title":"National prostate cancer audit","year":"2025"},{"key":"10.1016\/j.clon.2026.104069_bib2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.clon.2013.10.006","article-title":"The National Prostate Cancer Audit \u2013 Introducing a New Generation of Cancer Audit","volume":"26","author":"Aggarwal","year":"2014","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2026.104069_bib3","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1016\/S1470-2045(24)00665-X","article-title":"The National Cancer Audit Collaborating Centre (NATCAN): improving the quality of National Health Service cancer care in England and Wales","volume":"26","author":"Aggarwal","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2026.104069_bib4","series-title":"National Prostate Cancer Audit First Year Annual Report \u2013 Organisation of services and analysis of existing clinical data","year":"2014"},{"key":"10.1016\/j.clon.2026.104069_bib5","series-title":"National Prostate Cancer Audit (NPCA) state of the nation report","year":"2025"},{"key":"10.1016\/j.clon.2026.104069_bib6","series-title":"Prostate cancer: diagnosis and management [C] Evidence review for radical radiotherapy","year":"2019"},{"key":"10.1016\/j.clon.2026.104069_bib7","series-title":"National Prostate Cancer Audit Fourth Year Annual Report \u2013 Results of the NPCA Prospective Audit in England and Wales for men diagnosed 1 April 2015 \u2013 March 2016","year":"2017"},{"key":"10.1016\/j.clon.2026.104069_bib8","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.ijrobp.2017.07.040","article-title":"National Population-Based Study Comparing Treatment-Related Toxicity in Men Who Received Intensity Modulated Versus 3-Dimensional Conformal Radical Radiation Therapy for Prostate Cancer","volume":"99","author":"Sujenthiran","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2026.104069_bib9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.clon.2020.02.004","article-title":"Comparison of Treatment-Related Toxicity With Hypofractionated or Conventionally Fractionated Radiation Therapy for Prostate Cancer: A National Population-Based Study","volume":"32","author":"Sujenthiran","year":"2020","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2026.104069_bib10","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.ijrobp.2020.07.031","article-title":"Toxicity of Pelvic Lymph Node Irradiation With Intensity Modulated Radiation Therapy for High-Risk and Locally Advanced Prostate Cancer: A National Population-Based Study Using Patient-Reported Outcomes","volume":"108","author":"Parry","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2026.104069_bib11","series-title":"National Prostate Cancer Audit Fifth Year Annual Report \u2013 Results of the NPCA Prospective Audit in England and Wales for men diagnosed 1 April 2016 \u2013 March 2017","year":"2019"},{"key":"10.1016\/j.clon.2026.104069_bib12","series-title":"National Prostate Cancer Audit Sixth Year Annual Report \u2013 Results of the NPCA Prospective Audit in England and Wales for men diagnosed 1 April 2017 \u2013 March 2018","year":"2020"},{"key":"10.1016\/j.clon.2026.104069_bib13","series-title":"National Prostate Cancer Audit Seventh Year Annual Report \u2013 Results of the NPCA Prospective Audit in England and Wales for men diagnosed 1 April 2018 \u2013 March 2019","year":"2021"},{"key":"10.1016\/j.clon.2026.104069_bib14","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1200\/JCO.19.01538","article-title":"Patent-Reported Functional Outcomes After Hypofractionated or Conventionally Fractionated Radiation for Prostate Cancer: A National Cohort Study in England","volume":"38","author":"Nossiter","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2026.104069_bib15","series-title":"NICE real-world evidence framework","year":"2022"},{"key":"10.1016\/j.clon.2026.104069_bib16","series-title":"NPCA outlier policy 2025","year":"2025"},{"key":"10.1016\/j.clon.2026.104069_bib17","series-title":"NPCA quality improvement plan 2024","year":"2024"},{"key":"10.1016\/j.clon.2026.104069_bib18","unstructured":"Cowling TE. Measurable, actionable, and improvable: a maxim for indicators to improve healthcare (Version 1). Zenodo. https:\/\/doi.org\/10.5281\/zenodo.15275057."},{"key":"10.1016\/j.clon.2026.104069_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.euo.2023.05.002","article-title":"Does Research from Clinical Trials in Metastatic Hormone-sensitive Prostate Cancer Treatment Translate into Access to Treatments for Patients in the \u201cReal World\u201d? A Systematic Review","volume":"7","author":"Dodkins","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.clon.2026.104069_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115335","article-title":"Are evidence-based guidelines translating into clinical practice? A national population-based study of the use of treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC) in England","volume":"220","author":"Dodkins","year":"2025","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2026.104069_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-071674","article-title":"Organisation and delivery of supportive services for patients with prostate cancer in the National Health Service in England and Wales: a national cross-sectional hospital survey and latent class analysis","volume":"13","author":"Dodkins","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.clon.2026.104069_bib22","series-title":"Webinar: the use of systemic anti-cancer treatment in metastatic prostate cancer","year":"2025"},{"key":"10.1016\/j.clon.2026.104069_bib23","series-title":"NPCA data dashboard","year":"2025"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655526000403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655526000403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T04:18:26Z","timestamp":1776140306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655526000403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":23,"alternative-id":["S0936655526000403"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2026.104069","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Future Directions of the National Prostate Cancer Audit","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2026.104069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Royal College of Radiologists. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104069"}}